Phyllodes tumours of the breast: a consensus review

BY Tan, G Acs, SK Apple, S Badve, IJ Bleiweiss… - …, 2016 - Wiley Online Library
Phyllodes tumours constitute an uncommon but complex group of mammary fibroepithelial
lesions. Accurate and reproducible grading of these tumours has long been challenging, …

[HTML][HTML] Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review

KL Mooney, LW Bassett, SK Apple - Modern Pathology, 2016 - Elsevier
Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in situ…

Interventional breast imaging: current procedures and assessing for concordance with pathology

LW Bassett, MC Mahoney, SK Apple - Radiologic Clinics of North America, 2007 - Elsevier
Minimally invasive breast biopsy procedures performed for suspicious imaging findings
have expanded the role of breast imaging in the management of breast diseases. The first …

Higher levels of GATA3 predict better survival in women with breast cancer

NK Yoon, EL Maresh, D Shen, Y Elshimali, S Apple… - Human pathology, 2010 - Elsevier
The GATA family members are zinc finger transcription factors involved in cell differentiation
and proliferation. GATA3 in particular is necessary for mammary gland maturation, and its …

Histopathologic Characteristics Predicting HER‐2/neu Amplification in Breast Cancer

R Prati, SK Apple, J He, JA Gornbein… - The breast …, 2005 - Wiley Online Library
The HER‐2/neu gene is a proto‐oncogene that is amplified in 10–30% of breast cancers.
New drugs for targeted therapy, such as Herceptin, are effective for patients with HER‐2/neu‐…

Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?

CN Burge, HR Chang, SK Apple - The Breast, 2006 - Elsevier
Core biopsies are commonly used in the diagnosis of breast cancer and often are the only
sample for providing prognostic and predictive markers prior to neoadjuvant chemotherapy. …

Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for …

SK Apple, JR Hecht, DN Lewin, SA Jahromi, WW Grody… - Human pathology, 1999 - Elsevier
The pathobiology of precursor lesions leading to invasive pancreatic adenocarcinoma
remains a controversial area, but knowledge of the mechanisms of tumorigenesis may lead to …

The impact of atypia/follicular lesion of undetermined significance and repeat fine‐needle aspiration: 5 years before and after implementation of the Bethesda System

…, SL Hirschowitz, PC Fung, SK Apple - Cancer …, 2014 - Wiley Online Library
BACKGROUND Limited studies have examined the impact of the Bethesda System for
Reporting Thyroid Cytopathology (BSRTC) and specifically the category of atypia or follicular …

Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer

…, N Rao, DY Lu, SK Apple - American journal of …, 2011 - academic.oup.com
Accurate determination of HER2/neu status in breast carcinoma is essential. Alteration of
preanalytic variables is known to affect HER2/neu results. American Society of Clinical …

Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer

…, C Thomssen, N Harbeck, L Wang, S Apple… - Breast cancer research …, 2010 - Springer
In breast cancer, recent studies suggest that the value of HER2 for predicting response to
anthracycline-based chemotherapy may be more likely related to the concomitant amplification …